Developmental and epileptic encephalopathy
ICD-10 G93.45 is a billable code used to indicate a diagnosis of developmental and epileptic encephalopathy.
Developmental and epileptic encephalopathy (DEE) is a group of severe neurological disorders characterized by developmental delays, cognitive impairment, and intractable seizures. These conditions often manifest in early childhood and are associated with a range of symptoms that can include intellectual disability, behavioral issues, and various forms of epilepsy. The pathophysiology of DEE is complex, often involving genetic mutations, structural brain abnormalities, and metabolic dysfunctions. Patients may experience a variety of comorbidities, including pain syndromes, autonomic disorders, and hydrocephalus, which can complicate their clinical management. The diagnosis typically requires a comprehensive evaluation, including neuroimaging, genetic testing, and electroencephalography (EEG) to assess seizure activity. Treatment is multidisciplinary, focusing on seizure control, developmental support, and addressing associated symptoms. The prognosis varies widely depending on the underlying cause and the severity of the condition, making early diagnosis and intervention crucial for improving outcomes.
Detailed neurological assessments, including seizure types, frequency, and developmental milestones.
Patients presenting with developmental delays and seizures, requiring EEG and neuroimaging.
Ensure comprehensive documentation of all neurological evaluations and interventions.
Growth and developmental assessments, family history, and psychosocial evaluations.
Children with unexplained developmental delays and seizures, requiring multidisciplinary evaluations.
Document any referrals to specialists and the outcomes of those evaluations.
Used to evaluate seizure activity in patients with DEE.
Document the indication for the EEG and findings.
Neurologists should ensure that EEG interpretations are clearly documented.
Key symptoms include developmental delays, intractable seizures, cognitive impairment, and behavioral issues. Patients may also experience associated conditions such as pain syndromes and autonomic dysfunction.
